HIVE (HIVE) chair Frank Holmes details options, RSUs and 425K shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
HIVE Digital Technologies Ltd. Executive Chairman Frank E. Holmes filed an initial statement of beneficial ownership showing existing equity awards and share holdings. The filing lists options to buy 500,000 shares at $1.08, 100,000 shares at $1.05, and 20,000 shares at $4.94 per share, with expirations between 2027 and 2030.
He also reports multiple blocks of restricted stock units, including 250,000 and 405,625 RSUs, each convertible into common stock on a one-for-one basis, with a mix of fully vested awards and grants scheduled to vest through 2027. Direct holdings also include 425,000 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
12 transactions reported
Mixed
12 txns
Insider
HOLMES FRANK E
Role
Executive Chairman
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Options (right to buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Options (right to buy) — 500,000 shares (Direct);
Restricted Stock Units — 250,000 shares (Direct);
Common Stock — 425,000 shares (Direct)
Footnotes (1)
- These options were granted on September 14, 2017 and are fully vested as of the date hereof. Represents an exercise price of $1.50 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. These options were granted on February 10, 2020 and are fully vested as of the date hereof. Represents an exercise price of $1.45 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. These options were granted on July 6, 2023 and are fully vested as of the date hereof. Represents an exercise price of $6.86 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.3875 reported by the Bank of Canada on March 27, 2026. Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock. The RSUs were issued on August 26, 2022 and are fully vested as of the date hereof. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 18, 2024 and are fully vested as of the date hereof. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on November 5, 2024. 312,50 RSUs are fully vested, and the remaining 187,500 vest in three equal installments of on each of May 5, 2026, August 6, 2026 and November 6, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on February 14, 2025 and are fully vested as of the date hereof. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on April 17, 2025 and will vest in one installment on April 17, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on July 8, 2025 and will vest in one installment on July 8, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on October 31, 2025 and will vest in one installment on October 31, 2026. Each RSU represents the right to receive, at settlement, one share of common stock. The RSUs were issued on March 16, 2026 and will vest in one installment on March 16, 2027.
Key Figures
Option grant: 500,000 shares at $1.08
Option grant: 100,000 shares at $1.05
Option grant: 20,000 shares at $4.94
+4 more
7 metrics
Option grant
500,000 shares at $1.08
Options to buy HIVE common stock, expiring September 14, 2027
Option grant
100,000 shares at $1.05
Options to buy HIVE common stock, expiring February 10, 2030
Option grant
20,000 shares at $4.94
Options to buy HIVE common stock, expiring July 6, 2028
RSU award
250,000 RSUs
Each RSU represents one HIVE common share; fully vested as of filing date
RSU award
405,625 RSUs
Each RSU represents one HIVE common share; fully vested as of filing date
RSU award
500,000 RSUs
Each RSU represents one HIVE common share; partly vesting through November 6, 2026
Common stock holding
425,000 shares
Directly held HIVE common stock reported by Frank E. Holmes
Key Terms
Restricted Stock Unit, exercise price, fully vested, settlement, +1 more
5 terms
Restricted Stock Unit financial
"Each Restricted Stock Unit ("RSU") represents the right to receive, at settlement, one share of common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
exercise price financial
"Represents an exercise price of $1.50 Canadian dollars, converted to U.S. dollars at the daily average exchange rate..."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
fully vested financial
"These options were granted on September 14, 2017 and are fully vested as of the date hereof."
settlement financial
"Each RSU represents the right to receive, at settlement, one share of common stock."
Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.
installments financial
"The RSUs were issued on November 5, 2024... the remaining 187,500 vest in three equal installments..."
FAQ
What does Frank E. Holmes report owning in HIVE (HIVE) on this Form 3?
Frank E. Holmes reports existing holdings of options, restricted stock units, and common shares of HIVE Digital Technologies Ltd. The filing shows several option grants, multiple RSU awards tied one-for-one to common stock, and 425,000 directly held common shares.
What stock options does Frank E. Holmes hold in HIVE (HIVE)?
He holds options to buy 500,000 HIVE common shares at an exercise price of $1.08, 100,000 shares at $1.05, and 20,000 shares at $4.94. These options have expiration dates ranging from September 2027 through February 2030.
How many HIVE (HIVE) restricted stock units are reported for Frank E. Holmes?
The filing lists several RSU awards for Holmes, including 250,000, 405,625, 500,000, 200,000 and multiple 400,000-unit grants. Each restricted stock unit represents the right to receive one share of HIVE common stock upon settlement, with vesting schedules extending into 2026 and 2027.
Are Frank E. Holmes’s HIVE (HIVE) equity awards vested?
Many of Holmes’s options and RSUs are described as fully vested as of the filing date, while others have future vesting dates in 2026 and 2027. The footnotes specify grant dates and whether each award is fully vested or subject to scheduled vesting installments.
What do the exercise prices on Frank E. Holmes’s HIVE (HIVE) options represent?
The stated exercise prices of $1.08, $1.05, and $4.94 per share represent the U.S. dollar amounts required to purchase each underlying HIVE common share. Footnotes explain these figures reflect Canadian dollar grant prices converted using Bank of Canada exchange rates.